13.94USD-0.85%Mkt Cap: 1.93B USDP/E: —Last update: 2026-06-01
Intellia Therapeutics, Inc. operates as a clinical-stage genome editing company focused on developing potentially curative therapeutics using CRISPR/Cas9-based technologies. The company offers clustered, regularly inters…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.93B USD
Enterprise Value1.67B USD
Revenue (TTM)66.09M USD
Gross Profit-230.67M USD
Net Income (TTM)-412.69M USD
Revenue/Share0.5890 USD
Last Price13.94 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees377
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS45826J1051
Valuation
P/E (Trailing)—
P/E (Forward)-7.65
PEG—
EV/EBITDA-4.06
EV/Revenue25.27
P/S29.74
P/B2.73
EPS (TTM)-3.52
EPS (Forward)-1.84
52W Range
6.83033% of range28.25
52W High28.25 USD
52W Low6.830 USD
Profitability
Gross Margin0.00%
Oper. Margin-668.07%
EBITDA Margin0.00%
Profit Margin-609.85%
ROE-61.47%
ROA-49.01%
Growth
Revenue Growth-9.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-394.74M USD
CapEx (TTM)1.13M USD
FCF Margin-355.92%
FCF Yield-12.22%
Net Debt-295.50M USD
Net Debt/EBITDA0.72
Balance Sheet
Debt/Equity0.14
Current Ratio6.10
Quick Ratio5.04
Book Value/Sh5.155 USD
Cash/Share2.691 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.1 (Buy)
Target (Mean)26.63 USD
Target Range8.000 USD – 95.00 USD
# Analysts19
Ownership
Shares Out.139.72M
Float134.16M
Insiders3.83%
Institutions76.76%
Short Interest
Short Ratio6.2d
Short % Float46.78%
Short % Out.37.11%
Shares Short51.85M
Short (prev mo.)38.81M
Technical
SMA 5013.56 (+2.8%)
SMA 20013.26 (+5.1%)
Beta1.93
S&P 52W Chg27.94%
Avg Vol (30d)7.60M
Avg Vol (10d)7.14M
Technical Indicators
RSI (14)55.1
MACD-0.1286
MACD Signal-0.2148
MACD Hist.+0.0862
BB Upper14.84 USD
BB Middle13.36 USD
BB Lower11.89 USD
BB Width22.08%
ATR (14)1.001 USD
Vol Ratio (20d)0.60x